ArticleGut and liver2021

Efficacy and Safety of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C: A Pooled Analysis of Five Phase II/III Trials.

Jeong Heo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.